ARTELO BIOSCIENCES, INC. Increase (Decrease) in Prepaid Expense
ARTELO BIOSCIENCES, INC. (ARTL) reported Increase (Decrease) in Prepaid Expense of $169.26 thousand for the 12-month period ending 2020-08-31, per its 10-K filed 2020-11-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2020-11-04
- ARTELO BIOSCIENCES, INC. increase (decrease) in prepaid expense for the quarter ending 2020-08-31 was $113.24K.
- ARTELO BIOSCIENCES, INC. increase (decrease) in prepaid expense for the quarter ending 2020-05-31 was -$33.04K.
- ARTELO BIOSCIENCES, INC. increase (decrease) in prepaid expense for the quarter ending 2020-02-29 was $11.27K.
- ARTELO BIOSCIENCES, INC. increase (decrease) in prepaid expense for the quarter ending 2019-11-30 was $77.80K, a 722.20% increase year-over-year.
- ARTELO BIOSCIENCES, INC. increase (decrease) in prepaid expense for fiscal 2020 was $169.26K.
- ARTELO BIOSCIENCES, INC. increase (decrease) in prepaid expense for fiscal 2019 was -$27.05K, a 176.44% decline from fiscal 2018.
- ARTELO BIOSCIENCES, INC. increase (decrease) in prepaid expense for fiscal 2018 was $35.38K, a 2258.93% increase from fiscal 2017.
- ARTELO BIOSCIENCES, INC. increase (decrease) in prepaid expense for fiscal 2017 was $1.50K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 9 month as first filed | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|---|
| 2020-08-31 | $113.24K derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-04 | $80.19K derived: sum of 2 quarters · filed 2020-11-04 | $91.47K derived: sum of 3 quarters · filed 2020-11-04 | $169.26K 10-K · filed 2020-11-04 | |
| 2020-05-31 | -$33.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-07-13 | -$21.77K derived: sum of 2 quarters · filed 2020-07-13 | $56.03K 10-Q · filed 2020-07-13 | $53.12K derived: sum of 4 quarters · filed 2020-11-04 | |
| 2020-02-29 | $11.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-04-13 | $89.07K 10-Q · filed 2020-04-13 | $86.16K derived: sum of 3 quarters · filed 2020-11-04 | $81.32K derived: sum of 4 quarters · filed 2020-11-04 | |
| 2019-11-30 | $77.80K 10-Q · filed 2020-01-14 | $74.89K derived: sum of 2 quarters · filed 2020-11-04 | $70.04K derived: sum of 3 quarters · filed 2020-11-04 | $41.29K derived: sum of 4 quarters · filed 2020-11-04 | |
| 2019-08-31 | -$2.91K derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-04 | -$7.75K derived: sum of 2 quarters · filed 2020-11-04 | -$36.51K derived: sum of 3 quarters · filed 2020-11-04 | -$27.05K 10-K · filed 2020-11-04 | |
| 2019-05-31 | -$4.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-07-13 | -$33.60K derived: sum of 2 quarters · filed 2020-07-13 | -$24.14K 10-Q · filed 2020-07-13 | -$8.96K 10-Q · filed 2019-07-15 | -$45.10K derived: sum of 4 quarters · filed 2020-07-13 |
| 2019-02-28 | -$28.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-04-13 | -$19.30K 10-Q · filed 2020-04-13 | -$40.25K derived: sum of 3 quarters · filed 2020-04-13 | $3.67K derived: sum of 4 quarters · filed 2020-04-13 | |
| 2018-11-30 | $9.46K 10-Q · filed 2020-01-14 | -$11.49K derived: sum of 2 quarters · filed 2020-01-14 | $32.42K derived: sum of 3 quarters · filed 2020-01-14 | $30.06K derived: sum of 4 quarters · filed 2020-01-14 | |
| 2018-08-31 | -$20.95K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-12-18 | $22.96K derived: sum of 2 quarters · filed 2019-12-18 | $20.60K derived: sum of 3 quarters · filed 2019-12-18 | $35.38K 10-K/A · filed 2019-12-18 | |
| 2018-05-31 | $43.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-07-15 | $41.55K derived: sum of 2 quarters · filed 2019-07-15 | $56.34K 10-Q · filed 2019-07-15 | ||
| 2018-02-28 | -$2.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-04-15 | $12.42K 10-Q · filed 2019-04-15 | |||
| 2017-11-30 | $14.79K 10-Q · filed 2019-01-14 | ||||
| 2017-08-31 | $1.50K 10-K · filed 2018-11-29 | ||||
| 2017-02-28 | $2.56K 10-Q/A · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |